Physiological monitor
A patient monitor has multiple sensors adapted to attach to tissue sites of a living subject. The sensors generate sensor signals that are responsive to at least two wavelengths of optical radiation after attenuation by pulsatile blood within the tissue sites.
1. A physiological monitor comprising:
interface componentry in communication with at least two sensors adapted to be positioned on tissue sites of a patient, the interface componentry having at least two outputs corresponding to signals received from the at least two sensors and responsive to light transmitted through corresponding tissue sites; and
at least one signal processor in communication with the interface componentry outputs, the at least one signal processor configured to:
receive a first output, from the interface componentry, associated with a first tissue site of a first limb of the patient;
receive a second output, from the interface componentry, associated with a second tissue site on a second limb of the patient;
determine at least one first oxygen saturation measurement from the first tissue site and at least one second oxygen saturation measurement from the second tissue site in response to the first output and the second output;
determine the presence of a heart abnormality of an infant based at least in part on a comparison of the at least one first oxygen saturation measurement with the at least one second oxygen saturation; and
display an indication of the heart abnormality.
2. The physiological monitor of claim 1 , wherein the at least one signal processor is further configured to determine the heart abnormality is a patent ductus arteriosus, based, at least in part, on a determination that a difference between the at least one first oxygen saturation measurement and the at least one second oxygen saturation measurement is substantially zero.
3. The physiological monitor of claim 2 , wherein the at least one signal processor is further configured to:
determine plethysmograph measurements from the first tissue site and the second tissue site; and
compare at least one first plethysmograph measurement from the first tissue site with a second plethysmograph measurement from the second tissue site,
wherein the determination of the patent ductus arteriosus is further based on the comparison between the at least one first plethysmograph measurement and the at least one second plethysmograph measurement.
4. The physiological monitor of claim 3 , wherein the comparison between the at least one first plethysmograph measurement and the at least one second plethysmograph measurement identifies a phase difference between the at least one first plethysmograph measurement and the at least one second plethysmograph measurement.
5. The physiological monitor of claim 4 , wherein the determination of the patent ductus arteriosus is based at least in part on a determination that the phase difference is substantially non-zero.
6. The physiological monitor of claim 3 , wherein the comparison between the at least one first plethysmograph measurement and the at least one second plethysmograph measurement identifies a relative amount of damping between the at least one first plethysmograph measurement and the at least one second plethysmograph measurement.
7. The physiological monitor of claim 6 , wherein the determination of the patent ductus arteriosus is based at least in part on a determination that the relative amount of damping is substantially non-zero.
8. The physiological monitor of claim 1 , wherein a first sensor of the at least two sensors is configured to output the first output and be positioned on a right arm and a second sensor of the at least two sensors is configured to output the second output and be positioned on one of a left foot or a left hand.
9. A method for determining a heart abnormality in an infant, the method comprising:
using a pulse oximeter to determine a first oxygen saturation measurement from a first tissue site on a first limb of a patient;
using the pulse oximeter to determine a second oxygen saturation measurement from at least one additional tissue site on a second limb of the patient;
determining the presence of a heart abnormality of an infant based at least in part on a comparison of the first oxygen saturation measurement with the second oxygen saturation measurement; and
determining and displaying an indication of the heart abnormality on a display device of the pulse oximeter.
10. The method of claim 9 , further comprising detecting a patent ductus arteriosus, based at least in part, on a determination that the difference between the first oxygen saturation measurement and the second oxygen saturation measurement is substantially zero.
11. The method of claim 10 , wherein detecting a patent ductus arteriosus is further based on a determination of a phase difference between a first plethysmograph measurement at the first tissue site and a second plethysmograph measurement at the second tissue site.
12. The method of claim 11 , wherein the phase difference is substantially non-zero.
13. The method of claim 10 , wherein detecting a patent ductus arteriosus is further based on a determination of a relative amount of damping between a first plethysmograph measurement at the first tissue site and a second plethysmograph measurement at the second tissue site.
14. The method of claim 13 , wherein the relative amount of damping is substantially non-zero.
15. The method of claim 9 , wherein the first limb of the patient is a right arm and the second limb of the patient is one of a left foot or a left hand.